Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACTICS: TACE with Sorafenib in Unresectable HCC
NCT01217034Phase 2Unknown
- Sponsor
- Kindai University
- Start
- Oct 2010
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Kindai University. Status: unknown.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01217034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217034.